SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-23-276086
Filing Date
2023-11-13
Accepted
2023-11-13 16:31:28
Documents
92
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d549858d10q.htm   iXBRL 10-Q 1502016
2 EX-3.2 d549858dex32.htm EX-3.2 190682
3 EX-31.1 d549858dex311.htm EX-31.1 10962
4 EX-31.2 d549858dex312.htm EX-31.2 11241
5 EX-32.1 d549858dex321.htm EX-32.1 5640
  Complete submission text file 0001193125-23-276086.txt   7474884

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA selb-20230930.xsd EX-101.SCH 56371
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE selb-20230930_cal.xml EX-101.CAL 56576
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE selb-20230930_def.xml EX-101.DEF 274733
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE selb-20230930_lab.xml EX-101.LAB 489314
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE selb-20230930_pre.xml EX-101.PRE 406054
86 EXTRACTED XBRL INSTANCE DOCUMENT d549858d10q_htm.xml XML 1062613
Mailing Address 65 GROVE STREET WATERTOWN MA 02472
Business Address 65 GROVE STREET WATERTOWN MA 02472 617-923-1400
Cartesian Therapeutics, Inc. (Filer) CIK: 0001453687 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37798 | Film No.: 231399372
SIC: 2834 Pharmaceutical Preparations